SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-154568
Filing Date
2016-11-03
Accepted
2016-11-03 16:14:18
Documents
3
Period of Report
2016-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-17113_38k.htm 8-K 21530
2 EX-99.1 a16-17113_3ex99d1.htm EX-99.1 90664
3 GRAPHIC g171133mmi001.jpg GRAPHIC 3424
  Complete submission text file 0001104659-16-154568.txt   118198
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 161971748
SIC: 2834 Pharmaceutical Preparations